Mirror Biologics has a total of 67 patents globally, out of which 46 have been granted. Of these 67 patents, more than 86% patents are active. The United States of America is where Mirror Biologics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Mirror Biologics.
Mirror Biologics was founded in 2019. Mirror Biologics creates advanced vaccines and therapies that harness the immune system to fight cancer and infectious diseases.
Do read about some of the most popular patents of Mirror Biologics which have been covered by us in this article and also you can find Mirror Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mirror Biologics patent portfolio.
How many patents does Mirror Biologics have?
Mirror Biologics has a total of 67 patents globally. These patents belong to 9 unique patent families. Out of 67 patents, 58 patents are active.
How Many Patents did Mirror Biologics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Mirror Biologics Applications Filed | Mirror Biologics Patents Granted |
2014 | 6 | 6 |
2023 | 6 | 2 |
2022 | 1 | 1 |
2021 | 1 | 5 |
2020 | 3 | 5 |
2019 | 2 | 4 |
2018 | 2 | – |
2017 | 3 | 3 |
2016 | 7 | 6 |
2015 | 5 | – |
How many Mirror Biologics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Mirror Biologics File in Different Countries?
Countries in which Mirror Biologics Filed Patents
Country | Patent |
United States Of America | 61 |
Austria | 1 |
Taiwan | 1 |
China | 1 |
Europe | 1 |
Germany | 1 |
Where are Research Centers of Mirror Biologics Patents Located?
The Research Centers of Mirror Biologics Patents is the United States of America.
10 Best Mirror Biologics Patents
US7402431B2 is the most popular patent in the Mirror Biologics portfolio. It has received 111 citations so far from companies like Immunovative Therapies, Novartis, Agenus.
Below is the list of 10 most cited patents of Mirror Biologics:
Publication Number | Citation Count |
US7402431B2 | 111 |
US7435592B2 | 91 |
US7678572B2 | 36 |
US8012750B2 | 29 |
US7592431B2 | 29 |
US20110142887A1 | 19 |
US7972594B2 | 12 |
US8071374B2 | 11 |
US20130066465A1 | 10 |
US9782463B2 | 9 |
What Percentage of Mirror Biologics US Patent Applications Were Granted?
Mirror Biologics (Excluding its subsidiaries) has filed 59 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 43 have been granted leading to a grant rate of 82.69%.
Below are the key stats of Mirror Biologics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Mirror Biologics?
Law Firm | Total Applications | Success Rate |
Westman Champlin & Koehler PA | 55 | 83.33% |
Z Peter Sawicki | 4 | 75% |
What are Mirror Biologics key innovation segments?
What Technologies are Covered by Mirror Biologics?
The chart below distributes patents filed by Mirror Biologics